Halozyme Therapeutics Analyst Ratings

BenzingaNov 20 23:10 · Ratings

H.C. Wainwright Maintains Halozyme Therapeutics(HALO.US) With Buy Rating, Maintains Target Price $68

Futu NewsNov 20 22:31 · Ratings

3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)

Zacks Nov 20 00:55

HALO Vs. FOLD: Which Stock Should Value Investors Buy Now?

Zacks Nov 19 23:50

Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now?

Yahoo FinanceNov 19 22:40

Evotec Plunges Amid Report It's Against Halozyme Therapeutics Takeover

Seeking AlphaNov 19 21:47